This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both an ethylpiperazine and an amine group, makes it valuable for developing compounds with potential therapeutic effects, particularly in the realm of central nervous system (CNS) drugs. It is often incorporated into molecules designed to target receptors in the brain, such as those involved in mood regulation or neurological disorders. Additionally, its chemical properties make it suitable for further functionalization, enabling the creation of diverse derivatives for drug discovery and development.